Indication
Add-on treatment for adult patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis.
Medicine details
- Medicine name:
- benralizumab (Fasenra)
- SMC ID:
- SMC2870
- Pharmaceutical company
- AstraZeneca UK Ltd
- BNF chapter
- Respiratory system
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- TBC